Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 12, 2012 - Issue 9
Submit an article Journal homepage
201
Views
19
CrossRef citations to date
0
Altmetric
Review

Hypnic headache and caffeine

Dagny Holle Department of Neurology, University of Duisburg-Essen, Essen, Germany. [email protected]
&
Mark Obermann Department of Neurology, University of Duisburg-Essen, Essen, Germany
Pages 1125-1132 | Published online: 09 Jan 2014

References

  • Cerminara C, Compagnone E, Coniglio A et al. Hypnic headache in children. Cephalalgia 31(16), 1673–1676 (2011).
  • The International Headache society. The International Classification of Headache Disorders (2nd Edition). Cephalalgia 24(Suppl. 1), 9–160 (2004).
  • Holle D, Naegel S, Krebs S et al. Clinical characteristics and therapeutic options in hypnic headache. Cephalalgia 30(12), 1435–1442 (2010).
  • Manni R, Sances G, Terzaghi M, Ghiotto N, Nappi G. Hypnic headache: PSG evidence of both REM- and NREM-related attacks. Neurology 62(8), 1411–1413 (2004).
  • Holle D, Wessendorf TE, Zaremba S et al. Serial polysomnography in hypnic headache. Cephalalgia 31(3), 286–290 (2011).
  • Peatfield RC, Mendoza ND. Posterior fossa meningioma presenting as hypnic headache. Headache 43(9), 1007–1008 (2003).
  • Valentinis L, Tuniz F, Mucchiut M et al. Hypnic headache secondary to a growth hormone-secreting pituitary tumour. Cephalalgia 29(1), 82–84 (2009).
  • Garza I, Oas KH. Symptomatic hypnic headache secondary to a nonfunctioning pituitary macroadenoma. Headache 49(3), 470–472 (2009).
  • Moon HS, Chung CS, Hong SB, Kim YB, Chung PW. A case of symptomatic hypnic headache syndrome. Cephalalgia 26(1), 81–83 (2006).
  • Fredholm BB, Bättig K, Holmén J, Nehlig A, Zvartau EE. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol. Rev. 51(1), 83–133 (1999).
  • Sawynok J. Adenosine and ATP receptors. In: Handbook of Experimental Pharmacology (Volume 177). Stein C (Ed.). Springer, Berlin, Germany, 301–320 (2006).
  • Sawynok J, Yaksh TL. Caffeine as an analgesic adjuvant: a review of pharmacology and mechanisms of action. Pharmacol. Rev. 45(1), 43–85 (1993).
  • Sawynok J. Methylxanthines and pain. Handb. Exp. Pharmacol. 200, 311–329 (2011).
  • Godfrey L, Yan L, Clarke GD, Ledent C, Kitchen I, Hourani SMO. Modulation of paracetamol antinociception by caffeine and by selective adenosine A2 receptor antagonists in mice. Eur. J. Pharmacol. 531(1–3), 80–86 (2006).
  • Siegers CP. Effects of caffeine on the absorption and analgesic efficacy of paracetamol in rats. Pharmacology 10(1), 19–27 (1973).
  • Esser MJ, Sawynok J. Caffeine blockade of the thermal antihyperalgesic effect of acute amitriptyline in a rat model of neuropathic pain. Eur. J. Pharmacol. 399(2–3), 131–139 (2000).
  • Ulugol A, Karadag HC, Tamer M, Firat Z, Aslantas A, Dokmeci I. Involvement of adenosine in the anti-allodynic effect of amitriptyline in streptozotocin-induced diabetic rats. Neurosci. Lett. 328(2), 129–132 (2002).
  • Yaba G, Sezer Z, Tekol Y. Interaction between venlafaxine and caffeine on antinociception in mice. Pharmazie 61(1), 60–62 (2006).
  • Sawynok J, Reid AR, Fredholm BB. Caffeine reverses antinociception by amitriptyline in wild type mice but not in those lacking adenosine A1 receptors. Neurosci. Lett. 440(2), 181–184 (2008).
  • Tomic MA, Vuckovic SM, Stepanovic-Petrovic RM, Ugresic N, Prostran MS, Boskovic B. Peripheral anti-hyperalgesia by oxcarbazepine: involvement of adenosine A1 receptors. Pharmazie 61(6), 566–568 (2006).
  • Sawynok J, Reid AR, Fredholm BB. Caffeine reverses antinociception by oxcarbazepine by inhibition of adenosine A1 receptors: insights using knockout mice. Neurosci. Lett. 473(3), 178–181 (2010).
  • Gayawali K, Pandhi P, Sharma PL. Determination of the optimal analgesia-potentiating dose of caffeine and a study of its effect on the pharmacokinetics of aspirin in mice. Methods Find. Exp. Clin. Pharmacol. 13(8), 529–533 (1991).
  • Granados-Soto V, Castañeda-Hernández G. A review of the pharmacokinetic and pharmacodynamic factors in the potentiation of the antinociceptive effect of nonsteroidal anti-inflammatory drugs by caffeine. J. Pharmacol. Toxicol. Methods 42(2), 67–72 (1999).
  • Díaz-Reval MI, Ventura-Martínez R, Hernández-Delgadillo GP, Domínguez-Ramírez AM, López-Muñoz FJ. Effect of caffeine on antinociceptive action of ketoprofen in rats. Arch. Med. Res. 32(1), 13–20 (2001).
  • López JRM, Domínguez-Ramírez AM, Cook HJ et al. Enhancement of antinociception by co-administration of ibuprofen and caffeine in arthritic rats. Eur. J. Pharmacol. 544(1–3), 31–38 (2006).
  • Castañeda-Hernández G, Castillo-Méndez MS, López-Muñoz FJ, Granados-Soto V, Flores-Murrieta FJ. Potentiation by caffeine of the analgesic effect of aspirin in the pain-induced functional impairment model in the rat. Can. J. Physiol. Pharmacol. 72(10), 1127–1131 (1994).
  • López-Muñoz FJ, Castañeda-Hernández G, Flores-Murrieta FJ, Granados-Soto V. Effect of caffeine coadministration and of nitric oxide synthesis inhibition on the antinociceptive action of ketorolac. Eur. J. Pharmacol. 308(3), 275–277 (1996).
  • Aguirre-Bañuelos P, Castañeda-Hernández G, López-Muñoz FJ, Granados-Soto V. Effect of coadministration of caffeine and either adenosine agonists or cyclic nucleotides on ketorolac analgesia. Eur. J. Pharmacol. 377(2–3), 175–182 (1999).
  • Fiebich BL, Lieb K, Hüll M et al. Effects of caffeine and paracetamol alone or in combination with acetylsalicylic acid on prostaglandin E(2) synthesis in rat microglial cells. Neuropharmacology 39(11), 2205–2213 (2000).
  • Person DL, Kissin I, Brown PT, Xavier AV, Vinik HR, Bradley EL. Morphine–caffeine analgesic interaction in rats. Anesth. Analg. 64(9), 851–856 (1985).
  • Malec D, Michalska E. The effect of methylxanthines on morphine analgesia in mice and rats. Pol. J. Pharmacol. Pharm. 40(3), 223–232 (1988).
  • Ahlijanian MK, Takemori AE. Effects of (-)-N6-(R-phenylisopropyl)-adenosine (PIA) and caffeine on nociception and morphine-induced analgesia, tolerance and dependence in mice. Eur. J. Pharmacol. 112(2), 171–179 (1985).
  • Misra AL, Pontani RB, Vadlamani NL. Potentiation of morphine analgesia by caffeine. Br. J. Pharmacol. 84(4), 789–791 (1985).
  • Fredholm BB, Chern Y, Franco R, Sitkovsky M. Aspects of the general biology of adenosine A2A signaling. Prog. Neurobiol. 83(5), 263–276 (2007).
  • Huang ZL, Urade Y, Hayaishi O. The role of adenosine in the regulation of sleep. Curr. Top. Med. Chem. 11(8), 1047–1057 (2011).
  • Fredholm BB, IJzerman AP, Jacobson KA, Linden J, Müller CE. International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors – an update. Pharmacol. Rev. 63(1), 1–34 (2011).
  • Methippara MM, Kumar S, Alam MN, Szymusiak R, McGinty D. Effects on sleep of microdialysis of adenosine A1 and A2A receptor analogs into the lateral preoptic area of rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 289(6), R1715–R1723 (2005).
  • Satoh S, Matsumura H, Hayaishi O. Involvement of adenosine A2A receptor in sleep promotion. Eur. J. Pharmacol. 351(2), 155–162 (1998).
  • Scammell TE, Gerashchenko DY, Mochizuki T et al. An adenosine A2A agonist increases sleep and induces Fos in ventrolateral preoptic neurons. Neuroscience 107(4), 653–663 (2001).
  • Urade Y, Eguchi N, Qu WM et al. Sleep regulation in adenosine A2A receptor-deficient mice. Neurology 61(11 Suppl. 6), S94–S96 (2003).
  • Huang ZL, Qu WM, Eguchi N et al. Adenosine A2A, but not A1, receptors mediate the arousal effect of caffeine. Nat. Neurosci. 8(7), 858–859 (2005).
  • Dodick DW, Mosek AC, Campbell JK. The hypnic (‘alarm clock’) headache syndrome. Cephalalgia 18(3), 152–156 (1998).
  • Evers S, Rahmann A, Schwaag S, Lüdemann P, Husstedt IW. Hypnic headache – the first German cases including polysomnography. Cephalalgia 23(1), 20–23 (2003).
  • Brainin M, Barnes M, Baron JC et al. Guideline Standards Subcommittee of the EFNS Scientific Committee. Guidance for the preparation of neurological management guidelines by EFNS scientific task forces – revised recommendations 2004. Eur. J. Neurol. 11(9), 577–581 (2004).
  • Marziniak M, Voss J, Evers S. Hypnic headache successfully treated with botulinum toxin type A. Cephalalgia 27(9), 1082–1084 (2007).
  • Ghiotto N, Sances G, Di Lorenzo G et al. Report of eight new cases of hypnic headache and mini-review of the literature. Funct. Neurol. 17(4), 211–219 (2002).
  • Guido M, Specchio LM. Successful treatment of hypnic headache with topiramate: a case report. Headache 46(7), 1205–1206 (2006).
  • Dodick DW, Jones JM, Capobianco DJ. Hypnic headache: another indomethacin-responsive headache syndrome? Headache 40(10), 830–835 (2000).
  • Pinessi L, Rainero I, Cicolin A, Zibetti M, Gentile S, Mutani R. Hypnic headache syndrome: association of the attacks with REM sleep. Cephalalgia 23(2), 150–154 (2003).
  • Prakash S, Dabhi AS. Relapsing remitting hypnic headache responsive to indomethacin in an adolescent: a case report. J. Headache Pain 9(6), 393–395 (2008).
  • Lisotto C, Rossi P, Tassorelli C, Ferrante E, Nappi G. Focus on therapy of hypnic headache. J. Headache Pain 11(4), 349–354 (2010).
  • Raskin NH. The hypnic headache syndrome. Headache 28(8), 534–536 (1988).
  • Lisotto C, Mainardi F, Maggioni F, Zanchin G. Episodic hypnic headache? Cephalalgia 24(8), 681–685 (2004).
  • Donnet A, Lantéri-Minet M. A consecutive series of 22 cases of hypnic headache in France. Cephalalgia 29(9), 928–934 (2009).
  • Liang JF, Fuh JL, Yu HY, Hsu CY, Wang SJ. Clinical features, polysomnography and outcome in patients with hypnic headache. Cephalalgia 28(3), 209–215 (2008).
  • Pinto CA, Fragoso YD, Souza Carvalho D, Gabbai AA. Hypnic headache syndrome: clinical aspects of eight patients in Brazil. Cephalalgia 22(10), 824–827 (2002).
  • Martins IP, Gouveia RG. Hypnic headache and travel across time zones: a case report. Cephalalgia 21(9), 928–931 (2001).
  • Dodick DW. Polysomnography in hypnic headache syndrome. Headache 40(9), 748–752 (2000).
  • Morales-Asín F, Mauri JA, Iñiguez C, Espada F, Mostacero E. The hypnic headache syndrome: report of three new cases. Cephalalgia 18(3), 157–158 (1998).
  • Patsouros N, Laloux P, Ossemann M. Hypnic headache: a case report with polysomnography. Acta Neurol. Belg. 104(1), 37–40 (2004).
  • Arjona JA, Jiménez-Jiménez FJ, Vela-Bueno A, Tallón-Barranco A. Hypnic headache associated with stage 3 slow wave sleep. Headache 40(9), 753–754 (2000).
  • Goadsby PJ, Lipton RB. A review of paroxysmal hemicranias, SUNCT syndrome and other short-lasting headaches with autonomic feature, including new cases. Brain 120(Pt 1), 193–209 (1997).
  • Autunno M, Messina C, Blandino A, Rodolico C. Hypnic headache responsive to low-dose topiramate: a case report. Headache 48(2), 292–294 (2008).
  • Newman LC, Lipton RB, Solomon S. The hypnic headache syndrome: a benign headache disorder of the elderly. Neurology 40(12), 1904–1905 (1990).
  • Ivañez V, Soler R, Barreiro P. Hypnic headache syndrome: a case with good response to indomethacin. Cephalalgia 18(4), 225–226 (1998).
  • Pérez-Martínez DA, Berbel-García A, Puente-Muñoz AI et al. [Hypnic headache: a new case]. Rev. Neurol. 28(9), 883–884 (1999).
  • Vieira Dias M, Esperança P. [Hypnic headache: a report of four cases]. Rev. Neurol. 34(10), 950–951 (2002).
  • Centonze V, D’Amico D, Usai S, Causarano V, Bassi A, Bussone G. First Italian case of hypnic headache, with literature review and discussion of nosology. Cephalalgia 21(1), 71–74 (2001).
  • Buzzi MG, Cologno D, Formisano R, Caltagirone C. Hypnic headache responsive to indomethacin: second Italian case. Funct. Neurol. 20(2), 85–87 (2005).
  • Ulrich K, Gunreben B, Lang E, Sittl R, Griessinger N. Pregabalin in the therapy of hypnic headache. Cephalalgia 26(8), 1031–1032 (2006).
  • Zanchin G, Lisotto C, Maggioni F. The hypnic headache syndrome: the first description of an Italian case. J. Headache Pain 1, 60 (2000).
  • Peters N, Lorenzl S, Fischereder J, Bötzel K, Straube A. Hypnic headache: a case presentation including polysomnography. Cephalalgia 26(1), 84–86 (2006).
  • Seidel S, Zeitlhofer J, Wöber C. First Austrian case of hypnic headache: serial polysomnography and blood pressure monitoring in treatment with indomethacin. Cephalalgia 28(10), 1086–1090 (2008).
  • Sibon I, Ghorayeb I, Henry P. Successful treatment of hypnic headache syndrome with acetazolamide. Neurology 61(8), 1157–1158 (2003).
  • Gould JD, Silberstein SD. Unilateral hypnic headache: a case study. Neurology 49(6), 1749–1751 (1997).
  • Laska EM, Sunshine A, Mueller F, Elvers WB, Siegel C, Rubin A. Caffeine as an analgesic adjuvant. JAMA 251(13), 1711–1718 (1984).
  • Schachtel BP, Thoden WR, Konerman JP, Brown A, Chaing DS. Headache pain model for assessing and comparing the efficacy of over-the-counter analgesic agents. Clin. Pharmacol. Ther. 50(3), 322–329 (1991).
  • Migliardi JR, Armellino JJ, Friedman M, Gillings DB, Beaver WT. Caffeine as an analgesic adjuvant in tension headache. Clin. Pharmacol. Ther. 56(5), 576–586 (1994).
  • Lipton RB, Stewart WF, Ryan RE Jr, Saper J, Silberstein S, Sheftell F. Efficacy and safety of acetaminophen, aspirin, and caffeine in alleviating migraine headache pain: three double-blind, randomized, placebo-controlled trials. Arch. Neurol. 55(2), 210–217 (1998).
  • Diamond S, Balm TK, Freitag FG. Ibuprofen plus caffeine in the treatment of tension-type headache. Clin. Pharmacol. Ther. 68(3), 312–319 (2000).
  • Zhang WY. A benefit–risk assessment of caffeine as an analgesic adjuvant. Drug Saf. 24(15), 1127–1142 (2001).
  • Ward N, Whitney C, Avery D, Dunner D. The analgesic effects of caffeine in headache. Pain 44(2), 151–155 (1991).
  • Thornberry EA, Thomas TA. Posture and post-spinal headache. A controlled trial in 80 obstetric patients. Br. J. Anaesth. 60(2), 195–197 (1988).
  • Camann WR, Murray RS, Mushlin PS, Lambert DH. Effects of oral caffeine on postdural puncture headache. A double-blind, placebo-controlled trial. Anesth. Analg. 70(2), 181–184 (1990).
  • Griffiths RR, Evans SM, Heishman SJ et al. Low-dose caffeine physical dependence in humans. J. Pharmacol. Exp. Ther. 255(3), 1123–1132 (1990).
  • Griffiths RR, Woodson PP. Caffeine physical dependence: a review of human and laboratory animal studies. Psychopharmacology (Berl.) 94(4), 437–451 (1988).
  • Fennelly M, Galletly DC, Purdie GI. Is caffeine withdrawal the mechanism of postoperative headache? Anesth. Analg. 72(4), 449–453 (1991).
  • Hampl KF, Schneider MC, Rüttimann U, Ummenhofer W, Drewe J. Perioperative administration of caffeine tablets for prevention of postoperative headaches. Can. J. Anaesth. 42(9), 789–792 (1995).
  • Weber JG, Ereth MH, Danielson DR. Perioperative ingestion of caffeine and postoperative headache. Mayo Clin. Proc. 68(9), 842–845 (1993).
  • Diener HC, Limmroth V. Medication-overuse headache: a worldwide problem. Lancet Neurol. 3(8), 475–483 (2004).
  • Hering-Hanit R, Gadoth N. Caffeine-induced headache in children and adolescents. Cephalalgia 23(5), 332–335 (2003).

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.